![]() Avrobio Clinical stage company developing step-change cell and gene therapies targeting cancer and rare disease. | ![]() Senti Biosciences Senti Biosciences (formerly known as Dynamics Special Purpose) leverages expertise in cell engineering and biological programming to build the future of gene and cell based therapies. | |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Cambridge, US HQ | Locations South San Francisco, US HQ |
Employees | Employees 8573% increase | Employees 916% decrease |
Valuation ($) | Valuation ($) 5.2 m | Valuation ($) 10.2 m |
Financial | ||
Net income | Net income ($74.2m) (FY, 2025) | Net income ($61.4m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 85m | Total funding raised $ 53m |

Senti Biosciences (formerly known as Dynamics Special Purpose) leverages expertise in cell engineering and biological programming to build the future of gene and cell based therapies.
View company